Cardama Alfonso Quintas
- SEC CIK
- 0001760104
No open-market purchases or sales filed in the past year.
Current role at each company
- FHTX Foghorn Therapeutics Inc.Chief Medical Officeras of Feb 2, 2026
- TCRR TCR2 Therapeutics Inc.Chief Medical Officeras of Jun 1, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cardama Alfonso Quintas as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
TCRR TCR2 Therapeutics Inc.
Chief Medical Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2022 (view filing) | Dec 9-13 | 4 days | Cardama Alfonso QuintasChief Medical Officer | SSale | −13.8K | $1.10 | −$15.1K | −11.2%109.5K after | 3 lots |
| Dec 9, 2022 (view filing) | Dec 7-8 | 2 days | Cardama Alfonso QuintasChief Medical Officer | SSale | −7.94K | $1.27 | −$10.1K | −6.1%123.3K after | 2 lots |
| Dec 7, 2022 (view filing) | Dec 5-6 | 2 days | Cardama Alfonso QuintasChief Medical Officer | SSale | −7.46K | $1.35 | −$10.1K | −5.4%131.2K after | 2 lots |
| Dec 5, 2022 (view filing) | Dec 2 | 3 days | Cardama Alfonso QuintasChief Medical Officer | SSale | −3.64K | $1.39 | −$5.05K | −2.6%138.7K after |